MedTrace Logo

Calcium Carbonate to Augment Labor Contractions

NCT06580782 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-10-23

No results posted yet for this study

Summary

The investigators think that calcium carbonate can act as an assistive medication to improve contractions during labor.

Conditions

  • Labor Dystocia
  • Labor Induction
  • Labor Augmentation

Interventions

DRUG

Calcium Carbonate 500 MG

Calcium Carbonate 500mg, orally, every 4 hours.

DRUG

Standard Dose Synthetic Pitocin

The participant will receive thestandard-dose synthetic oxytocin for labor induction or augmentation.

Sponsors & Collaborators

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Moeun Son, MD · Weill Medical College of Cornell University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-18
Primary Completion
2025-12-31
Completion
2025-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06580782 on ClinicalTrials.gov